Wall Street expects BWX Technologies to report Q3 2026 revenue of $715.4 million and EPS of $1.19, with the current stock price of $212.45 sitting below the average analyst target of $242.00. Investors are primarily focused on the expansion of the Commercial Power segment, specifically the progress of medical isotope commercialization and microreactor development.
Strong demand for naval nuclear propulsion and strategic wins in the small modular reactor (SMR) space have provided significant tailwinds over the past fiscal year. Analysts will be closely monitoring the company's multi-billion dollar backlog to gauge long-term revenue visibility amid the ongoing global nuclear energy renaissance.